AlphaNavi Pharma specializes in the research and development of new drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 5, 2019 | Series A | ¥0.90B | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
— | Series A |
|
— | Series A |